BioWorld Science

April 15, 2013

View Archived Issues

Development of small-molecule inhibitors of cancer-related transcription factors

Read More

Peptide-based anticancer vaccine J-65 induces tumor cell lysis

Read More

AstraZeneca presents novel dual inhibitor with activity against crizotinib-resistant cell lines

Read More

Researchers detail activity of Notch signaling inhibitor BMS-906024

Read More

Boston Therapeutics requests IND meeting for drug designed to reduce postprandial glucose

Read More

Preclinical data reported for a novel HIV integrase inhibitor

Read More

Galleon Pharmaceuticals demonstrates proof of concept for GAL-021

Read More

CvergenX and NCI to develop test to predict radiation therapy success

Read More

OTraces reports encouraging results from phase II testing of blood test for breast cancer

Read More

Novartis presents first data for mutant BRAF inhibitor LGX-818

Read More

Researchers present new data for MGL-3196

Read More

Wockhardt patents new agents for bacterial infections

Read More

Scientists at Novartis present novel c-Met inhibitors

Read More

Panacea Biotec discloses novel SGLT2 inhibitors

Read More

Scientists at Bayer synthesize novel CDK9/cyclin T1 inhibitors

Read More

Lilly presents preliminary results of clinical trial evaluating LY-2606368 monotherapy

Read More

AFFiRiS discloses new vaccines for lipoprotein and cardiovascular disorders

Read More

Elorac's naloxone lotion granted fast track designation for pruritus in CTCL

Read More

BioSante Pharmaceuticals and ANI Pharmaceuticals enter into new merger agreement

Read More

Roche and Ascletis collaborate on danoprevir in China

Read More

Enrollment completed in SIRFLOX metastatic colorectal cancer trial

Read More

Effects of dietary supplement on postprandial blood glucose tested in subjects with type 2 diabetes

Read More

Nestle Health Science and Chi-Med obtain regulatory approvals for joint venture

Read More

Biodesix and Bruker Daltonics establish new collaboration

Read More